Dr. Carlos in Brazil did not give up, and after the first patient abandoned treatment due to distrust, he contacted local medical associations and patient organizations to hold a small K Therapy educational session. Most of the attendees were late-stage patients and their families, their eyes revealing similar despair and longing.
Carlos did not conceal any information: effectiveness, side effects, economic burden, technical uncertainties. He showed the Sanbo training class operation videos and international case data, and also openly discussed the limitations of adenovirus antibody screening and current solutions.
"Doctor, we've understood what you've said," a middle-aged man consulting for his wife said, "but how do we know this isn't another scam? We've seen too many miracle therapies that end up being money pits."
